Precision Medicine Market to Reach US$ 105.6 Billion by 2026, Globally |CAGR: 9.9%| UnivDatos Market Insights

NOIDA, India, Dec. 1, 2020 /PRNewswire/ — A comprehensive overview of the precision medicine market is recently added by UnivDatos Market Insights to its humongous database. The precision medicine market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and opportunities. Furthermore, the precision medicine market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the precision medicine market at the global and regional levels. Global Precision Medicine Market is expected to grow at a CAGR of 9.9% from 2021-2026 to reach US$ 105.6 billion by 2026.

Market Overview

Precision medicine is known to be one of the most promising approaches for tackling the diseases that have thus far eluded effective treatments or cures. Several indications such as cancer, neurodegenerative diseases, and rare genetic conditions take an immense toll on individuals, families, and societies. Cancer is amongst the leading cause of mortality worldwide with an estimation of 9.6 million deaths in 2018. The most common cancers include lung (2.09 million cases), breast (2.09 million cases), colorectal (1.80 million cases), prostate (1.28 million cases), non-melanoma skin (1.04 million cases), stomach (1.03 million cases).

The rising demand for preventive care and advances in next-generation sequencing (NGS) technologies have resulted in an unprecedented proliferation and deluge of genomic sequence data, thereby driving the market growth of the precision medicine sector. In the last 15 years, the cost of mapping a human genome has fallen from US$ 100 million to below US$ 1,000, allowing the use of data from patient DNA to become a significant viable method to provide precise, actionable recommendations before symptoms occur. The growth of the industry is also fueled by scientific discovery, alignment of incentives, regulatory decisions, consumer interest and demand, and advances in technology. The growth of the market for precision medicine is also supported by the increasing patient adherence to treatment and rising prevalence of oncology indications.

Request Sample Copy of this Report @ https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026

Impact of COVID-19:

As the pandemic is spreading rapidly, clinicians treating COVID-19 are in desperate need of effective therapy, as the development of an effective vaccine remains a remote possibility. Given the urgent nature of the pandemic and the number of companies and researchers developing COVID-19 related therapies, there are more than 560 drug development programs in the pipeline with over 370 trials been reviewed by FDA. For instance, Boehringer Ingelheim initiated a Phase II study of BI 764198, a TRPC6 inhibitor to alleviate the damage to the lung and decrease the risk or severity of acute respiratory complications in patients hospitalized for COVID-19.

Ask for Price & Discounts @ https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026

Global Precision Medicine Market report is studied thoroughly with several aspects that would help stakeholders in making their decisions more curated.

By Technology, the market is primarily bifurcated into

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion
Read more

Regenerative Medicine Market Futuristic Comprehensive Insights with COVID-19 Impact Analysis | Organogenesis Inc, Osiris Therapeutics Inc

The MarketWatch News Department was not involved in the creation of this content.

Nov 29, 2020 (MarketResearch.biz via Comtex) —
A consciously conceived and designed business intelligence report titled Global Regenerative Medicine market 2020 by Manufacturers, Type, and Application, Forecast to 2029 by MarketResearch.biz discloses a succinct analysis of the regional spectrum, market size, and revenue forecast about the market. This report sheds light on the vital developments along with other events happening in the global Regenerative Medicine market which is marking on the enlargement and opening doors for outlook growth in the coming years.

This is the latest report, covering the current COVID-19/Corona Virus pandemic impact on the market which has affected every aspect of life globally. This has brought along several changes in market conditions and the Business areas. The rapidly changing market scenario and initial and future assessment of the impact are covered in the Regenerative Medicine market report. 

For All-Inclusive Information: Download a FREE sample copy of Regenerative Medicine Market Report Study 2020-2029 at https://marketresearch.biz/report/regenerative-medicine-market/request-sample

(Our FREE SAMPLE COPY of the report gives a brief introduction to the research report outlook, list of tables and figures, Impact Analysis of COVID-19, TOC, an outlook to key players of the market and comprising key regions.)

Competitive Analysis:

The major companies are exceedingly focused on innovation in Regenerative Medicine production technology to enhance ledge life and efficiency. The best long-term development path for Regenerative Medicine market can be caught by guaranteeing financial pliancy to invest in the optimal strategies and current process improvement.

Key manufacturers are included based on the company profile, sales data and product specifications, etc: Organogenesis Inc, Osiris Therapeutics Inc, Pfizer Inc, Novartis AG, Vericel Corporation, NuVasive Inc, Cook Biotech Inc, GlaxoSmithKline plc., Boehringer Ingelheim GmbH, Amgen Inc

Each manufacturer or Regenerative Medicine market player’s growth rate, gross profit margin, and revenue figures is provided in a tabular, simple format for few years and an individual section on Regenerative Medicine market recent development such as collaboration, mergers, acquisition, and any new service or new product launching in the market is offered.

Regenerative Medicine Market Segmentation Outlook By therapy, product type, application, and region:

By therapy: Cell Therapy Tissue Engineering Immunotherapy Gene Therapy By product type: Cell-Based Products Allogeneic Products Autologous Products Acellular Products By application: Orthopedic & Musculoskeletal Disorders Dermatology Cardiology Dermatology Diabetes Central Nervous System Disorders Others

Download Now And Browse Complete Information On The COVID 19 Impact Analysis On Regenerative Medicine Market: https://marketresearch.biz/report/regenerative-medicine-market/covid-19-impact

Regional Analysis:On the idea of geography, the Regenerative Medicine Market report covers statistics for a couple of geographies inclusive of, North America (U.S., Mexico, Canada) South America (Argentina, Brazil) The Middle East & Africa (South Africa, Saudi Arabia) Asia-Pacific (China, Japan, India, Southeast Asia) Europe (U.K., Spain, Italy, Germany, France, Russia)

In addition, The following years considered for this study to forecast the global Regenerative Medicine market size are as follows:

– Actual Year: 2019

– Estimated Year: 2020

– Forecast Year: 2020–2029

Some Fundamental Report Highlights:

– Thorough Outline

Read more

Global Herceptin Biosimilar Market to Surpass US$ 5.8 Billion by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global herceptin biosimilar market is estimated to be valued at US$ 1.3 billion in 2020 and is expected to exhibit a CAGR of 24.5 % over the forecast period (2020-2027).

Key Trends and Analysis of the Global Herceptin Biosimilar Market:

Key players are focused on obtaining product approvals to strengthen their position in the global herceptin biosimilar market. For instance, in June 2020, Roche Holding AG received the US Food Drug and Administration approval for Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase, a subcutaneous injection with combination with intravenous chemotherapy for treatment of early and metastatic breast cancer.

Moreover, key players are focused on launching products to strengthen their product portfolio in the global herceptin biosimilar market. For instance, in 2019, Samsungbioepis Co,.Ltd, received approval for its first oncology treatment, Ontruzant, a biosimilar of herceptin and received the approval from US Food Drug and Administration. The product is approved for treatment of metastatic HER2-overexpressing BC, early HER2-overexpressing BC, and advanced gastric cancer in the U.S.

Among regions, North America is expected to register highest growth rate due to the increasing prevalence of diseases such as colorectal cancer, breast cancer and lung cancer in women. The US National Library of Medicine’s report published in September 2020 stated that around breast, lung and colorectal cancer accounted for 50% of the overall cancer incidence in women in the US.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4258

Key Market Takeaways:

The global herceptin biosimilar market is expected to exhibit a CAGR of 24.5 % over the forecast period owing to the increasing prevalence of diseases such as gastric cancer and breast cancer in females and product approvals and launches in the global herceptin biosimilar market.

Competitive Landscape:

Key players operating in the global herceptin biosimilar market are Amgen Inc., AryoGen Biopharma, Biocon Limited, Celltrion Inc., Pfizer Inc., Merck & Co., Inc., Accord Healthcare Ltd, Gedeon Richter Plc, Genor Biopharma Company Ltd, Mabion SA, Mylan N.V, Roche Holding AG and Samsungbioepis Co,.Ltd.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4258

Market Segmentation:

  • Global Herceptin Biosimilar Market, By Indication:

    • Breast Cancer

    • Gastric Cancer

    • Others

  • Global Herceptin Biosimilar Market, By Distribution Channel :

    • Hospitals

    • Oncology Centers

    • Others

  • Global Herceptin Biosimilar Market, By Region:

    • North America

    • Latin America

      • By Country:

        • Brazil

        • Mexico

        • Argentina

        • Rest of Latin America

    • Europe

      • By Country:

        • Germany

        • U.K.

        • France

        • Italy

        • Spain

        • Russia

        • Rest of Europe

    • Asia Pacific

      • By Country:

        • China

        • India

        • Japan

        • Australia

        • South Korea

        • ASEAN

        • Rest of Asia Pacific

    • Middle East

      • By Country/Region:

        • GCC

        • Israel

        • Rest of Middle East

    • Africa

      • By Country/Region:

        • South Africa

        • Central Africa

        • North Africa

Related Market Intelligence Report:

Biosimilars Market, by Drug Class (Recombinant Human Growth Hormone, Granulocyte Colony-Stimulating Factor, Insulin, Anticoagulants, Fusion Proteins, Erythropoietin, Monoclonal Antibodies, Follitropin, and Others), by Therapy Type (Oncology, Immunology, Hematology, Hormone Therapy, Metabolic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Specialty Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) –

Read more

Sports Medicine Device Market Insights (2020 to 2025) – Analysis and Forecast for the Global and Chinese Markets – Press Release

Dublin, Nov. 02, 2020 (GLOBE NEWSWIRE) — The “Sports Medicine Device Market Insights 2020, Analysis and Forecast Global and Chinese Market to 2025, by Manufacturers, Regions, Technology, Product Type” report has been added to ResearchAndMarkets.com’s offering.

This report is a professional and in-depth study on the current state of the global Sports Medicine Device market with a focus on the Chinese market. The report provides key statistics on market of Sports Medicine Device. It is a valuable source of guidance and direction for companies and individuals interested in Sports Medicine Device industry.

Key points of Sports Medicine Device Market Report:
1. The report provides a basic overview of Sports Medicine Device industry including: definition, applications and manufacturing technology.
2. The report explores Global and Chinese major players in Sports Medicine Device market. In this part, the report presents the company profile, product specifications, capacity, production value, and 2015-2020 market shares for each company.
3. The report depicts the global and Chinese total Sports Medicine Device market including: capacity, production, production value, cost/profit, supply/demand and Chinese import/export, by statistical analysis.
4. The global Sports Medicine Device market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5. The report then estimates 2020-2025 development trends, analyse upstream raw materials, downstream demand, and current market dynamics of Sports Medicine Device market.
6. The report makes some important proposals for a new project of Sports Medicine Device Industry before evaluating its feasibility.
7. Overall, the report provides an in-depth insight of 2015-2025 global and Chinese Sports Medicine Device market covering all important parameters.

Main Parameters for this report:

Type Segment:

Companies Covered:

  • Arthrex
  • Smith & Nephew
  • Stryker
  • Depuy Synthes/Johnson & Johnson
  • Zimmer Biomet
  • Karl Storz
  • Conmed
  • Wright
  • Medshape
  • Valeris
  • Rog
  • Aceosteo
  • Asco Medical
  • Atlas Surgical
  • Auxein
  • Biotek
  • Bonetech Medisys
  • CHM
  • Egifix
  • Forerunner
  • Fxorthopedi
  • Gesco Medical
  • GPC Medical Ltd
  • Green Surgical
  • Griphorto
  • Hardik International
  • HIBS
  • Innomed Solutions
  • Jeil Medical
  • Jiangsu Bai De Medical Instrument
  • Marapole
  • Matrix
  • Medgal
  • Microport
  • Miraclus
  • Narang
  • Naton Group
  • Nebula

Key Topics Covered:

1.: Introduction of Sports Medicine Device Industry
1.1 Brief Introduction of Sports Medicine Device
1.2 Development of Sports Medicine Device Industry
1.3 Status of Sports Medicine Device Industry

2.: Manufacturing Technology of Sports Medicine Device
2.1 Development of Sports Medicine Device Manufacturing Technology
2.2 Analysis of Sports Medicine Device Manufacturing Technology
2.3 Trends of Sports Medicine Device Manufacturing Technology

3.: Analysis of Global Key Manufacturers
3.1 Arthrex
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Capacity Production Price Cost Production Value
3.1.4 Contact Information
3.2 Smith & Nephew
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Capacity Production Price Cost Production Value
3.2.4 Contact Information
3.3 Stryker
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Capacity Production Price Cost Production Value
3.3.4 Contact Information
3.4 Depuy Synthes/Johnson & Johnson
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Capacity Production Price Cost Production Value
3.4.4 Contact Information
3.5 Zimmer Biomet
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Capacity Production Price Cost Production Value
3.5.4 Contact Information
3.6 Karl

Read more

EPA/DHA (Omega3) Ingredients Market to reach $3.8 billion by 2026, Says Global Market Insights, Inc.

EPA/DHA (Omega3) Ingredients Industry projected to register more than 7% CAGR between 2020 and 2026, impelled by increasing consumer awareness for omega-3 fortified products.

Selbyville, Delaware, Oct. 29, 2020 (GLOBE NEWSWIRE) —

The EPA/DHA (omega3) ingredients market value is expected to cross USD 3.8 Billion by 2026, according to a new research report by Global Market Insights, Inc. Growing awareness about the functional benefits of EPA/DHA ingredients and increasing and increasing health care cost is anticipated to propel the industry outlook.

EPA/DHA (Omega3) Ingredients industry from EPA is expected to register over 8.6% CAGR through 2026, due to the virtue of increasing high quality supplements and increasing product penetration. Since, EPA fatty acid supplements help to support good heart health along with weight management, child development, and joint health. EPA metabolizes to produce hormone like substances called eicosanoids which are responsible regulating cell growth, muscle activity, hormone secretion and blood clotting. Thereby, demand for EPA/DHA(Omega3) ingredients is anticipated to grow. Moreover, rising incidences of various diseases like cardiovascular disease, diabetes and hormonal issues owing to hectic lifestyle and harmful dietary habits will boost product demand.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/118

The global economy is hit by COVID- 19 pandemic where, even after continuing the operations, many nations are facing challenges of resuming their production capacity and manufacturers are experiencing the effect of shortages in their distribution networks. However, increasing electricity demand and robust growth across the healthcare sector is anticipated to amplify the product installation.

Some major findings of the EPA/DHA (omega3) ingredients market report include:

  • The gradual shift of consumers towards dietary and functional food has gain traction owing to its high protein and nutrition content will foster the global Market trends.

  • Increasing incorporation of EPA/DHA ingredients in infant formulas is one of the defining trends which creates favourable market demand.

  • EPA/DHA (omega3) ingredients demand from animal & pet feed is expected to register over 9.8% CAGR through owing to increasing number of pet ownership.

  • High demand of clean label products is creating lucrative growth opportunities for the market.

  • EPA/DHA ingredients sourced from plant such as algae is likely to gain traction in the market due to increasing vegan population.

  • Key players operating in the market are continuously investing in research and development activities in order to monitor its product offerings and exhilarate ever rising demand of consumers.

  • Increasing application scope in cancer treatment may drive the industry demand. Rise in R&D expenditure to develop omega 3 clinical nutrition products and pharmaceutical drugs should have positive influence on product demand.

  • Some of the major players operating in the market are BASF, Koninklijke DSM N.V., Croda International plc, Omega Protein, Nordic Naturals, Inc., Copeinca ASA, Epax Norway AS, Arista Industries, Inc., GC Rieber, Solutex, Olvea and Lysi others.

Browse key industry insights spread across 300 pages with 396 market data tables and 30 figures & charts from the report, “EPA/DHA (Omega3) Ingredients Market Forecasts By Application (Dietary supplements, Pharmaceuticals, Functional Foods, Pet & Animal

Read more

Global Blood Ketone Meter Market to Surpass US$ 486.3 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global blood ketone meter market is estimated to be valued at US$ 301.7 million in 2020 and is expected to exhibit a CAGR of 7.1% during the forecast period (2020-2027).

Key Trends and Analysis of the market:

The increasing number of product launches is expected to drive growth of the blood ketone meter market during the forecast period. For instance, in March 2020, EKF Diagnostics, the global in vitro diagnostics company, announced the launch of the U.S. FDA CLIA-waived β-ketone and glucose POC analyzer STAT-Site WB Analyzer in the U.S. market. This device is a new addition to its diabetes care portfolio in the U.S. The STAT-Site WB is a dual-use whole blood β-ketone and glucose meter for professional use in the management of diabetes.

Key manufacturers operating in the blood ketone meter market are engaged in developing more advanced products for the ease of diabetes patients. For instance, blood glucose & ketone testing meter by Foracare Inc., called FORA 6 Gtel, is a device that comes with 3G/4G connectivity. It can seamlessly transfer data to a TeleHealth System without the need for pairing it with a smartphone. With 5-Electrode Technology and strips made with gold, FORA 6 test strips ensure high accuracy and precision. It measures six parameters such as glucose, hematocrit, hemoglobin, β-ketone, total cholesterol, and uric acid in blood.

The global blood ketone meter market is expected to witness significant growth, owing to increasing partnerships and collaborations. For instance, in February 2020, the global diabetes nonprofit Beyond Type 1 announced a new collaboration with the National Association of School Nurses to create awareness about the warning signs of type 1 diabetes (T1D). With this new collaboration, awareness materials will be distributed to tens of thousands of school nurses nationally in the U.S. Moreover, Beyond Type 1 advocates will be enhancing efforts in ten target states: Arkansas, Connecticut, Florida, Massachusetts, New Jersey, North Carolina, Ohio, Oklahoma, Pennsylvania, and Texas.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/3498

Key Market Takeaways:

The global blood ketone meter market is expected to exhibit a CAGR of 7.1% during the forecast period (2020-2027), owing to the rising prevalence of type 1 diabetes worldwide. For instance, according to the National Diabetes Statistics Report by Centers for Disease Control and Prevention of 2017, around 1.25 million Americans suffered from type 1 diabetes and over 300,000 Canadians lived with type 1 diabetes in 2017. Furthermore, as per the same source, over 100,000 children in India and 50,000 children and adolescents in China were living with type 1 diabetes as of 2017.

Key players in the North America blood ketone meter market are focused on launching new products, which is expected to drive growth of the market during the forecast period. For instance, in March 2020, EKF Diagnostics launched the STAT-Site WB, a blood β-ketone and glucose meter in the U.S. The device is used for measuring ketone and for the management of diabetes.

Competitive Landscape:

Key players

Read more

Hair Transplant Market revenue to cross USD 40 Bn by 2026: Global Market Insights, Inc.

Some of the major hair transplant market players include Allergan Plc, Bernstein Medical, Bosley, GETFUE Hair Clinics Ltd., Hair Restoration BlackRockHRBR, Hair Club, Venus Concept (NeoGraft), Hairline International Hair and Skin Clinic, Hair Transplant Centre Turkey, Hair Transplants of Florida, Cole Instruments Inc. among others.

Selbyville, Delaware, Oct. 26, 2020 (GLOBE NEWSWIRE) —

According to latest report “Hair Transplant Market by Method (Follicular Unit Extraction [FUE], Follicular Unit Transplantation [FUT]), Product (Gel, Serum, Drugs, Multivitamins), Therapy (Platelet Rich Plasma, Stem Cell Therapy, Laser Therapy), Gender (Male, Female), Service Provider (Hospitals, Clinics, Surgical Centers), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026”, by Global Market Insights, Inc., the market valuation of hair transplant will cross $40.1 billion by 2026.

Rise in number of people suffering from hair loss in Middle East and Africa region will act as a high impact rendering factor for the market growth. Increase in number of people suffering from hair loss in the Middle Eastern countries has resulted in more young men opting for hair transplant procedures. The major factors contributing to male pattern baldness are stress, genetics, illness or medication, climatic and water condition along with physiological factors such as malnutrition and ageing. According to the recently published article, around 60% of the male population in Middle East region is expected to experience hair loss in their lifetime, as compared to global average of 40%.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2810

Recent technological advancements, automation and cost-effectiveness of hair transplant procedure will drive the market value. Rising demand for single session hair restoration surgeries coupled with increase in awareness regarding physical appearance will further propel the market revenue.

Follicular unit extraction (FUE) segment in the hair transplant market valued more than USD 3,270 million in 2019 impelled by the rising number of men suffering from pattern baldness and growing adoption of the technologically advanced hair transplant methods by the surgeons. Furthermore, growing prevalence of alopecia cases coupled with increase in aging population base across the globe will fuel the segment growth in the coming years.

The hair transplant market for drugs segment is predicted to witness 25.5% growth rate from 2020 to 2026. The enhancement in alopecia treatment is mainly driven by the growing demand for hair loss treatment drugs that have shown higher effectiveness along with minimal side effects. In addition, increasing investment made by the leading players to develop novel hair transplant drugs will further boost the market expansion.

Platelet rich plasma (PRP) therapy in the hair transplant market accounted for USD 358 million in 2019. PRP is considered as one of the innovative and technological advanced hair transplant therapies for the patients suffering from hair thinning. PRP contains more than 20 growth factors that are considered exceptional for hair regrowth by stimulating the new hair cells and hence, this procedure will showcase higher adoption than other therapies.

Hair transplant market from male patient segment is estimated to expand at 25.8% CAGR through 2026 owing

Read more

The Future of Food With SIAL Insights And SIAL Innovation

SIAL Paris, the world’s foremost food industry trade fair remains true to its mission: federate and guide the transformation of the sector’s companies on a global scale, despite the postponement of its physical edition to October 2022.

“It was important to share in a digital webinar the trendbook ‘SIAL Insights’ which was the culmination of large-scale studies performed in 2020 by our expert partners Kantar, Gira and ProtéinesXTC” said Nicolas Trentesaux, CEO of SIAL Global Network.

“The surveys were conducted with regard to the theme #Ownthechange, which resonates even more deeply today. The results are an important source of information for all those seeking to understand the challenges, trends and innovations that are shaping this period,” pursued Adeline Vancauwelaert, General Manager of SIAL Paris.

The studies show that food is becoming a statement: citizenship, involvement, and commitment are the by-words, and COVID-19 is catalyzing the trend.

73% of consumers have changed their eating habits over the last two years. 63% consider that the way they eat is a societal commitment, meaning choosing the world in which they want to live. 33% have reclaimed their power by adopting at least one major behavioral change or by boycotting certain brands or products. Their motivation? A healthier diet (70%), more local and seasonal food (53%), free of controversial ingredients (44%). The trend extends to stores, where healthy products are increasingly abundant, and to a lesser extent to restaurants, which are putting more emphasis on traceability, local and seasonal products, and shorter menus.

Regarding the food industry, pleasure and health are motors for innovation, with three major trends: back to basics, as local as possible, understated enjoyments.

The SIAL Innovation Awards 2020 shows the intention on the part of industrials to propose products that address the profound consumer desire for change. Out of 500 applications received, the jury awarded 17 prizes among 8 categories and 6 special prizes. The Grands Prix are:

Gold: BOCON (IT) for their frozen vegetable Gnocchi (70% vegetable) and combination of spices.

Silver: PATISSERIE DES FLANDRES (FR) for their Origine labeled Maroilles cheese flavoured mini waffles. A fresh product that only needs 5m in the oven for a quick snack or a cocktail party.

Bronze: TRIUMPH (FR) for Toogood Chewing Gum, a natural gum without aspartame that biodegrades in 3 months versus 5 years.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005021/en/

Contacts

Isabelle Cremoux-Mirgalet
[email protected]

Source Article

Read more

Global IV Infusion Bottle Seals & Caps Market to Surpass US$ 124.9 Million by 2027, Says Coherent Market Insights (CMI)

According to Coherent Market Insights, the global IV infusion bottle seals & caps market is estimated to be valued at US$ 104.3 million in 2020 and is expected to exhibit a CAGR of 2.6% over the forecast period (2020-2027).

Key Trends and Analysis of the Global IV infusion bottle seals & caps Market:

Key trends in the market include rising incidence of multiple sclerosis, arthritis, congestive heart failure, increasing launches of IV products, launch of new programs, and adoption of expansion strategies by the companies.

Rising incidence of chronic diseases such as multiple sclerosis, arthritis, congestive heart failure, and some types of immune deficiency disorders is expected to drive demand for infusion therapies, thereby contributing to significant growth of the IV infusion bottle seals & caps market. For instance, according to the National Center for Biotechnology Information (NCBI), 2020, in the year 2017, globally, around 126 million people suffered from ischemic heart disease (1,655 per 100,000). Furthermore, according to the World Federation of Hemophilia (WFH) 2018 statistics, around 440,000 people suffered from hemophilia, of which around 173,000 people were diagnosed with hemophilia A or B in 2017, globally.

Moreover, rising launches of IV products, in order to address the healthcare needs is the major factor, which is expected to drive the market growth over the forecast period. For instance, in June 2029, Eurolife Healthcare, a manufacturer and distributor specialty Infusion & pharmaceuticals, launched Discport and Lifeport IV products in India. These products are the replacement to the currently used polypropylene bottles (FFS bottles).

Moreover, market players are involved in launching new programs for patient safety, in order to increase the use of IV therapy and this is expected to drive the market growth. For instance, in April 2019, Becton, Dickson and Company (BD) launched a new program for patient safety in hospitals, called as PRIME (Preventing Risks of Infections and Medication Errors in IV Therapy). PRIME was developed in partnership with the Joint Commission International (JCI) for patient safety and aimed to address the challenges in a hospital setting regarding medical safety and infection prevention.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4238

Key Market Takeaways:

The global IV infusion bottle seals & caps market is expected to exhibit a CAGR of 2.6% over the forecast period, owing to facility expansion of pharmaceutical plastic packaging, which is expected to drive the market growth. For instance, in May 2018, Gerresheimer, a manufacturer of specialist packaging for drugs, announced the expansion of its facility in the Brazil. The new Gerresheimer Anápolis plant has commenced production in the Brazilian state of Goiás, for the production of the entire range of plastic containers from PP, PE, and PET, along with the corresponding closures and caps.

Competitive Landscape:

Key players operating in the global IV infusion bottle seals & caps market include Cardinal Health Inc., Jiangsu changjiang Lids, Taiwan Hon Chuan Enterprise, PrasadMeditech, Winfield Laboratories Inc., Datwyler HoldingAG, Wuxi Qitian Medical Technology Co., Ltd, Medline Industries Inc., RENOLITSE, and B. Braun Medical Inc.

Read more